CEO interview from DNB North American Life Science Conference

10. Jan 2020 | 0 min read

CEO interview from DNB North American Life Science Conference

Gentian’s CEO Dr Hilja Ibert was interviewed at DNB North American Life Science Conference in December 2019. In this interview she talks about Gentian as a company working towards diagnostic efficiency, our immunoassays and the outlook for 2020.

See the whole interview here.

You may also read


Collaboration Proposal - COVID-19

Apr 03, 2020

Collaboration Proposal - COVID-19

We at Gentian AS believe it is the duty of all companies in the health industry to help combat the ongoing..

Statement to Customers on COVID-19 Concerns

Mar 13, 2020

Statement to Customers on COVID-19 Concerns

At Gentian, the health and safety of our employees, as well as our customers and partners, is of primary..

New article about calprotectin in Scientific Reports

Mar 11, 2020

New article about calprotectin in Scientific Reports

Calprotectin, a new biomarker for diagnosis of acute respiratory infections*